Exforge
Product Images NDC 54868-5804

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Exforge (NDC 54868-5804). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel – Package Label – 10 mg*/160 mg Tablets (5804)

Principal Display Panel – Package Label – 10 mg*/160 mg Tablets (5804)
FDA Label Image

Principal Display Panel – Package Label – 10 mg*/320 mg Tablets (5983)

Principal Display Panel – Package Label – 10 mg*/320 mg Tablets (5983)
FDA Label Image

Principal Display Panel – Package Label – 5 mg*/320 mg Tablets (5996)

Principal Display Panel – Package Label – 5 mg*/320 mg Tablets (5996)
This seems to be a partial text of an advertisement for a medication called Exforge. The dosage mentioned is 5ug/320mg. The name of the company or the manufacturer is not available in this text.*
FDA Label Image

Principal Display Panel – Package Label – 5 mg*/160 mg Tablets (5997)

Principal Display Panel – Package Label – 5 mg*/160 mg Tablets (5997)
FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Exforge 01)

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Exforge 01)
FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Exforge 02)

Figure 2: Probability Of Achieving Diastolic Blood Pressure <90 Mmhg At Week 8 (Exforge 02)
FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Exforge 03)

Figure 3: Probability Of Achieving Systolic Blood Pressure <130 Mmhg At Week 8 (Exforge 03)
FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Exforge 04)

Figure 4: Probability Of Achieving Diastolic Blood Pressure <80 Mmhg At Week 8 (Exforge 04)
FDA Label Image

Amlodipine Besylate Structural Formula (Exforge 05)

Amlodipine Besylate Structural Formula (Exforge 05)
FDA Label Image

Valsartan Structural Formula (Exforge 06)

Valsartan Structural Formula (Exforge 06)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.